Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ICMT | O60725 | 1/20 | 0.34 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SOS1 | Q07889 | 2/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.30 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23721906 | 0.99 | SLC6A4 (0.34) | ICMTCAMK2DSLC6A4SOS1HDAC1 | |
| SCHEMBL23745823 | 0.92 | CNR1 (0.38) | ICMTCAMK2DPADI4CNR1 | |
| Hydrochloric Acid SCHEMBL23722097 | 0.91 | CNR1 (0.38) | ICMTCAMK2DPADI4CNR1 | |
| SCHEMBL23745600 | 0.89 | CNR1 (0.35) | ICMTCNR1 | |
| Hydrochloric Acid SCHEMBL23722200 | 0.88 | CNR1 (0.34) | ICMTCNR1 | |
| SCHEMBL23745584 | 0.86 | HTR6 (0.37) | CAMK2DSLC6A4SOS1 | |
| SCHEMBL23745514 | 0.86 | SOS1 (0.48) | ICMTSLC6A4SOS1HDAC1HDAC8 | |
| Hydrochloric Acid SCHEMBL23721961 | 0.86 | HTR6 (0.37) | CAMK2DSLC6A4SOS1 | |
| SCHEMBL23745812 | 0.84 | SOS1 (0.42) | ICMTSLC6A4SOS1HDAC1HDAC8 | |
| Hydrochloric Acid SCHEMBL23721995 | 0.84 | SOS1 (0.41) | ICMTSLC6A4SOS1HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246115-A1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | FDPS, FPR1, F12 | ICMT 345/4885CAMK2D 4809/4885SLC6A4 4834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.